TY - JOUR
T1 - Physicians' participatory decision-making and quality of diabetes care processes and outcomes
T2 - Results from the triad study
AU - Heisler, M.
AU - Tierney, E.
AU - Ackermann, R. T.
AU - Tseng, C.
AU - Venkat Narayan, K. M.
AU - Crosson, J.
AU - Waitzfelder, B.
AU - Safford, M. M.
AU - Duru, K.
AU - Herman, W. H.
AU - Kim, C.
PY - 2009
Y1 - 2009
N2 - Objectives: In participatory decision-making (PDM), physicians actively engage patients in treatment and other care decisions. Patients who report that their physicians engage in PDM have better disease self-management and health outcomes. We examined whether physicians' diabetes-specific treatment PDM preferences as well as their self-reported practices are associated with the quality of diabetes care their patients receive. Methods: 2003 cross-sectional survey and medical record review of a random sample of diabetes patients (n = 4198) in 10 US health plans across the country and their physicians (n = 1217). We characterized physicians diabetes care PDM preferences and practices as no patient involvement, physician-dominant, shared, or patient-dominant and conducted multivariate analyses examining their effects on the following: (1) three diabetes care processes (annual hemoglobin A1c test; lipid test; and dilated retinal exam); (2) patientssatisfaction with physician communication; and (3) whether patients A1c, systolic blood pressure (SBP), and low-density lipoprotein cholesterol (LDL) were in control. Results: Most physicians preferred shared PDM (58%) rather than no patient involvement (9%), physiciandominant (28%) or patient dominant PDM (5%). However, most reported practicing physician-dominant PDM (43%) with most of their patients, rather than no patient involvement (13%), shared (37%) or patient-dominant PDM (7%). After adjusting for patient and physician-level characteristics and clustering by health plan, patients of physicians who preferred shared PDM were more likely to receive A1c tests [90% vs. 82%, AOR: 2.05, 95% CI: 1.03-3.07] and patients of physicians who preferred patient-dominant treatment decision-making were more likely to receive lipid tests [60% vs. 50%, AOR: 1.58, 95% CI: 1.04-2.39] than those of providers who preferred no patient involvement in treatment decision-making. There were no differences in patients satisfaction with their doctors communication or control of A1c, SBP or LDL depending on their physicians PDM preferences. Physicians self-reported PDM practices were not associated with any of the examined aspects of diabetes care in multivariate analyses. Conclusions: Patients whose physicians prefer more patient involvement in decision-making are more likely than patients whose physicians prefer more physician-directed styles to receive some recommended risk factor screening tests, an important first step toward improved diabetes outcomes. Involving patients in treatment decision-making alone, however, appears not to be sufficient to improve biomedical outcomes.
AB - Objectives: In participatory decision-making (PDM), physicians actively engage patients in treatment and other care decisions. Patients who report that their physicians engage in PDM have better disease self-management and health outcomes. We examined whether physicians' diabetes-specific treatment PDM preferences as well as their self-reported practices are associated with the quality of diabetes care their patients receive. Methods: 2003 cross-sectional survey and medical record review of a random sample of diabetes patients (n = 4198) in 10 US health plans across the country and their physicians (n = 1217). We characterized physicians diabetes care PDM preferences and practices as no patient involvement, physician-dominant, shared, or patient-dominant and conducted multivariate analyses examining their effects on the following: (1) three diabetes care processes (annual hemoglobin A1c test; lipid test; and dilated retinal exam); (2) patientssatisfaction with physician communication; and (3) whether patients A1c, systolic blood pressure (SBP), and low-density lipoprotein cholesterol (LDL) were in control. Results: Most physicians preferred shared PDM (58%) rather than no patient involvement (9%), physiciandominant (28%) or patient dominant PDM (5%). However, most reported practicing physician-dominant PDM (43%) with most of their patients, rather than no patient involvement (13%), shared (37%) or patient-dominant PDM (7%). After adjusting for patient and physician-level characteristics and clustering by health plan, patients of physicians who preferred shared PDM were more likely to receive A1c tests [90% vs. 82%, AOR: 2.05, 95% CI: 1.03-3.07] and patients of physicians who preferred patient-dominant treatment decision-making were more likely to receive lipid tests [60% vs. 50%, AOR: 1.58, 95% CI: 1.04-2.39] than those of providers who preferred no patient involvement in treatment decision-making. There were no differences in patients satisfaction with their doctors communication or control of A1c, SBP or LDL depending on their physicians PDM preferences. Physicians self-reported PDM practices were not associated with any of the examined aspects of diabetes care in multivariate analyses. Conclusions: Patients whose physicians prefer more patient involvement in decision-making are more likely than patients whose physicians prefer more physician-directed styles to receive some recommended risk factor screening tests, an important first step toward improved diabetes outcomes. Involving patients in treatment decision-making alone, however, appears not to be sufficient to improve biomedical outcomes.
KW - Diabetes
KW - Medical decision-making
KW - Patient-Physician relations
KW - Quality of Care
UR - http://www.scopus.com/inward/record.url?scp=71749114297&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=71749114297&partnerID=8YFLogxK
U2 - 10.1177/1742395309339258
DO - 10.1177/1742395309339258
M3 - Article
C2 - 19675116
AN - SCOPUS:71749114297
SN - 1742-3953
VL - 5
SP - 165
EP - 176
JO - Chronic Illness
JF - Chronic Illness
IS - 3
ER -